Loading organizations...
§ Private Profile · Aachen, Nordrhein-Westfalen, Germany
MedTech company developing AI-driven solutions for hospitals and ICUs, focused on acute and critical care digitalization and efficiency.
Clinomic is an Aachen, Germany-based medical technology company that develops innovative artificial intelligence solutions, including a voice-controlled bedside documentation and telemedicine system for intensive care units. Founded in 2019 by intensive care physicians Arne Peine and Lukas Martin from University Hospital RWTH Aachen, the enterprise focuses on acute care and hospital digitalization. The firm operates with a workforce of 51 to 100 employees and generates approximately $4,450,000 in annual revenue through hardware sales, data analysis services, and comprehensive hospital consulting operations. To date, the company has secured $42,600,000 in total funding across two rounds, reaching an estimated valuation of $14,300,000. Its flagship Mona system is currently utilized by 40,000 users across more than 40 hospitals in eight European countries, earning recognition in TIME magazine while the company pursues US FDA approval under CEO Georg Griesemann.
Clinomic has raised $27.0M across 1 funding round.
Clinomic has raised $27.0M in total across 1 funding round.
Clinomic has raised $27.0M in total across 1 funding round.
Clinomic's investors include DeepTech & Climate Fonds.
Clinomic has raised $27.0M across 1 funding round. Most recently, it raised $27.0M Series B in April 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 14, 2025 | $27M Series B | DeepTech & Climate Fonds | — | Announced |